Clinical sepsis phenotypes in critically ill COVID-19 patients

Background A greater understanding of disease heterogeneity may facilitate precision medicine for coronavirus disease 2019 (COVID-19). Previous work identified four distinct clinical phenotypes associated with outcome and treatment responses in non-COVID-19 sepsis patients, but it is unknown if and...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Critical care (London, England) Ročník 26; číslo 1; s. 1 - 6
Hlavní autori:	Bruse, Niklas, Kooistra, Emma J., Jansen, Aron, van Amstel, Rombout B. E., de Keizer, Nicolette F., Kennedy, Jason N., Seymour, Christopher, van Vught, Lonneke A., Pickkers, Peter, Kox, Matthijs
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 09.08.2022 BioMed Central Ltd Springer Nature B.V BMC
Predmet:	Blood Brief Report Care and treatment Coronaviruses COVID-19 Creatinine Critical care Critical Care Medicine Critically ill Dexamethasone Dosage and administration Emergency Medicine Genotype & phenotype Intensive Intensive care Medicine Medicine & Public Health Mortality Patients Personalized medicine Phenotypes Pneumonia Precision medicine Prevention Risk factors Sepsis Severe acute respiratory syndrome coronavirus 2 Steroids United States COVID-19 Sepsis Phenotypes Dexamethasone Personalized medicine
ISSN:	1364-8535, 1466-609X, 1364-8535, 1366-609X, 1466-609X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!